Antibacterial Drugs Market to Surpass US$ 49.7 Billion by 2026 - Coherent Market Insights

Published On : Feb 26, 2019

Global Antibacterial Drugs Market, by Drug class (Beta lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 43,791.2 million in 2017, and is projected to exhibit a CAGR of 1.4% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.

Increasing research and development by market players to augment the market growth

Key players in the market are focused on research and development in order to develop novel products to address the critical unmet needs of patients. For instance, in September 2018, the Pew Charitable Trusts reviewed the antibacterial agents in clinical development phase and they found around 42 antibacterial agents, which are under pipeline. Out of these, around 15 were in Phase 1 and Phase 12, around 11 were in Phase 2, around 11 were in phase 3, and 4 have been submitted to the national medicines authority.

Moreover, Relebactam + Imipenem/Cilastatin MK-7655A developed by Merck & Co., Inc., is under Phase 3 clinical trial indicated for treatment of Urinary Tract Infection.

Increase in antibacterial resistance, is expected to increase the research and development for innovative and novel antibacterial drugs, which in turn is expected to boost the market growth. In 2015, the World Health Organization (WHO) planned a preventive measure called as ‘Global Action Plan on Antimicrobial Resistance’, such initiatives are expected to get maximum benefits of drug in long term and launch of new drugs for better healthcare.

Browse 25 Market Data Tables and 27 Figures spread through 156 Pages and in-depth TOC on ‘Antibacterial Drugs Market’- Global Forecast to 2026, by Drug class (Beta lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) To know the latest trends and insights prevalent in the antibacterial drugs market, click the link below:

https://www.coherentmarketinsights.com/market-insight/antibacterial-drugs-market-177

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in January 2018, Melinta Therapeutics, Inc., announced the acquisition of The Medicines Company’s infectious disease business, this acquisition is expected to strengthen the Melinta’s infectious disease product portfolio and position it to be the leading antibiotics company.

Key Takeaways of the Antibacterial Drugs Market:

  • The global antibacterial drugs market is expected to exhibit a CAGR of 1.4% over the forecast period, owing to increasing incidences of infectious diseases, rising geriatric population prone to bacterial infection, government initiatives to control infectious diseases incidences, and risk associated with antibiotics resistance. Centers for Disease Control and Prevention (CDC), has taken an initiative of Antibiotic Resistance (AR) Solutions to detect, respond, contain, prevent and innovate strategies to combat with antibiotic resistance around world.
  • Among drug class, the beta lactams segment holds a dominant position in the antibacterial drugs market in 2018, owing to its high preference as antibiotics.
  • Among distribution channel, hospital segment hold a dominant position in the antibacterial drugs market in 2018, as majority of the cases of infectious diseases and other are registered at hospitals.
  • Key players operating in the global antibacterial drugs market include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc., Sanofi SA, Bayer AG, and Pfizer Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.